Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Avascular Necrosis
- Correction of Functional Deformity
- Degenerative Joint Disease of Knee
- Knee Osteoarthritis
- Rheumatoid Arthritis of Knee
- Traumatic Arthritis of Knee
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 21 years and 125 years
- Gender
- Both males and females
Description
The objectives of this study are: To estimate the individual component survivorship of EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur components, including EVOLUTION® CS tibial inserts To find out the cumulative incidence of component revision of each component in this combination. To f...
The objectives of this study are: To estimate the individual component survivorship of EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur components, including EVOLUTION® CS tibial inserts To find out the cumulative incidence of component revision of each component in this combination. To find out the functional outcome scores at early, midterm, and long term follow-up.
Tracking Information
- NCT #
- NCT04301622
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Brian de Beaubien, MD Covenant Medical Center
Get Well Soon